|
Real-time Estimate
Cboe BZX
21:22:29 04/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 220.98 USD | -1.57% |
|
+1.14% | +25.58% |
| 08:53am | Eisai, Biogen Secure China's Nod for Self-Injection Version of Leqembi | MT |
| 09-03 | Piper Sander Adjusts Biogen Price Target to $245 From $225, Maintains Overweight Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOGEN INC. | Biopharmaceuticals | -1.56% | +1.14% | +25.58% | +57.92% | -32.47% | 33.17B |  | | |
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
